1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

How do I...

Do you have questions on how to use the message boards? Want to know how to post, how to insert links, post polls, change your user options, etc.? Simply post your question here and we will answer as soon as possible.

Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    0
    Views:
    2,011
  2. Anonymous
    Replies:
    2
    Views:
    2,827
  3. Anonymous
    Replies:
    2
    Views:
    2,052
  4. Anonymous
    Replies:
    2
    Views:
    3,032
  5. Monicamesie
    Replies:
    0
    Views:
    1,809
  6. Anonymous
    Replies:
    0
    Views:
    1,993
  7. QA2REP
    Replies:
    0
    Views:
    1,751
  8. Anonymous
    Replies:
    3
    Views:
    2,358
  9. Anonymous
    Replies:
    15
    Views:
    39,788
  10. WayneChesterbrook
    Replies:
    3
    Views:
    6,533
  11. Anonymous
    Replies:
    0
    Views:
    1,712
  12. Anonymous
    Replies:
    0
    Views:
    1,537
  13. Anonymous
    Replies:
    0
    Views:
    1,978
  14. Anonymous
    Replies:
    0
    Views:
    1,573
  15. Anonymous
    Replies:
    0
    Views:
    1,675
  16. Anonymous
    Replies:
    0
    Views:
    1,558
  17. Anonymous
    Replies:
    0
    Views:
    1,437
  18. Anonymous
    Replies:
    0
    Views:
    1,324
  19. Anonymous
    Replies:
    5
    Views:
    1,622
  20. Anonymous
    Replies:
    7
    Views:
    3,905

Thread Display Options

Loading...